US Business

Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs.

BP said it would return less cash to shareholders after its profit came in worse than expected.

The premium sports-car maker cut its sales and profitability guidance for the year due in part to a hit from U.S. import tariffs.

The company confirmed its guidance for most of its divisions which is now expected to report an adjusted operating loss of up to 40 million pounds in fiscal year 2025.

The food-delivery company said it received a $3.59 billion takeover approach that it would be prepared to recommend to shareholders, if a formal offer were made.

The Volkswagen-owned commercial-vehicle maker said it was banking on an improved second-half after sales revenue dropped 10%.

The companies entered into a definitive deal for the acquisition of some Spirit industrial assets dedicated to Airbus’s commercial aircraft programs.

The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.

The Vietnamese conglomerate has postponed its initial public offering of more than $1.0 billion because of volatile global market conditions, according to people familiar with the situation.

A backlog of renewable energy projects is waiting to connect to the U.S. power grid. Tariffs on steel, aluminum, solar panels and battery components are adding to costs and delays.